The National Institutes of Health’s Rocky Mountain Laboratories (RML) in Hamilton, Montana, reported a potential theft, loss, or release of a highly dangerous select biological agent in November 2025.
- Documents obtained by the White Coat Waste Project reveal that RML’s November 2025 biosafety report noted: “Form 3 reported to Federal Select Agent Program on 11/13/2025.”
- Form 3 is the mandatory USDA-CDC notification for any theft, loss, or release of select agents—pathogens or toxins posing severe threats to public health, animal health, or plants, such as anthrax, plague, Ebola, or similar high-risk agents.
- RML is a high-containment NIH/NIAID facility with Biosafety Level 3 and 4 labs, conducting research on dangerous infectious diseases, including animal experiments.
- The specific agent involved has not been publicly disclosed, and no details on exposures, containment status, or resolution have been released.
- Neither NIH, RML, CDC, USDA, nor the Federal Select Agent Program has issued any public statements or further information about the incident.
- This filing highlights persistent concerns over biosafety and security lapses at taxpayer-funded high-risk labs handling potential pandemic pathogens.
- The story was exclusively broken by White Coat Waste Project, a group critical of animal research funding and practices at facilities like RML.
- Such incidents fuel scrutiny of government oversight, transparency, and risks from gain-of-function or high-containment research, especially given RML’s history tied to NIAID under former leadership.
- No confirmed public health impact has been reported, but the lack of disclosure raises alarms about accountability in federal biodefense operations.
Read the full story: https://www.infowars.com/posts/exclusive-federal-lab-in-montana-reports-potential-theft-loss-or-release-of-dangerous-biological-agent/
What Would You Do If Pharmacies Couldn’t Provide You With Crucial Medications or Antibiotics?
The medication supply chain from China and India is more fragile than ever since Covid. The US is not equipped to handle our pharmaceutical needs. We’ve already seen shortages with antibiotics and other medications in recent months and pharmaceutical challenges are becoming more frequent today.
Our partners at Jase Medical offer a simple solution for Americans to be prepared in case things go south. Their “Jase Case” gives Americans emergency antibiotics they can store away while their “Jase Daily” offers a wide array of prescription drugs to treat the ailments most common to Americans.
They do this through a process that embraces medical freedom. Their secure online form allows board-certified physicians to prescribe the needed drugs. They are then delivered directly to the customer from their pharmacy network. The physicians are available to answer treatment related questions.
